Aurobindo Pharma gets US FDA nod for anaesthetic injection

By: |
May 16, 2016 2:40 PM

The product is expected to be launched in the second quarter of 2016-17 fiscal, it added Aurobindo Pharma has received final nod from the US health regulator to manufacture and market its anaesthetic Bupivacaine Hydrochloride injection USP, 0.25 per cent (2.5 mg/mL) and 0.5 per cent (5 mg/mL) 50 mL multiple dose vials in the […]

The product is expected to be launched in the second quarter of 2016-17 fiscal, it added

Aurobindo Pharma has received final nod from the US health regulator to manufacture and market its anaesthetic Bupivacaine Hydrochloride injection USP, 0.25 per cent (2.5 mg/mL) and 0.5 per cent (5 mg/mL) 50 mL multiple dose vials in the US market.

The product is expected to be launched in the second quarter of 2016-17 fiscal, it added. The approved ANDA is generic version of Hospira’s Marcaine injection, it said.

The company said that the approved product has an estimated market size of
$5.6 million for the twelve months ended March 2016, according to IMS.

Bupivacaine Hydrochloride injection is used for the production of local or regional anaesthesia or analgesia for surgery, diagnostic and therapeutic procedures, and for obstetrical procedures, the company said.

The company has a total of 262 ANDA approvals (224 final approvals including 11 from Aurolife Pharma and 38 tentative approvals) from US FDA, it added.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1‘Some photographs are harder to copy’: Congress takes a jibe at PM Modi over his US flight pic
2‘Colonial mindset’: Indians lash out at UK’s ‘racist’ vaccine policy on Twitter
3Shiv Sena likens governors in non-BJP states to ‘rogue elephants’, says they are trampling democracy